AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Cost-Effective Care for Hair Loss: A Focus on Alopecia Management

Description

The presentation by Doctor Roman focuses on the cost-effective management of hair loss, particularly androgenetic alopecia and alopecia areata. These are common conditions affecting a significant portion of the population, with androgenetic alopecia impacting 50% of women and up to 80% of men by age 80. The hair loss market is projected to grow from $8 billion in 2023 to $15.3 billion by 2031. Women spend an average of $900 annually on hair products, often prioritizing hair care over other beauty expenses. Notably, black women contribute to a $3 billion industry, spending nine times more on ethnic hair products. Costs for managing alopecia areata include significant healthcare utilization, with additional expenses for compensating psychological impacts and necessary treatments, which can exceed $3,000 annually. Patients express willingness to spend $500 to $1,000 monthly for effective treatments. Managing expectations is crucial, as there is currently no cure for hair loss conditions. The main FDA-approved treatments include finasteride and topical minoxidil. The cost of treatments is substantial over time, often exceeding $100,000 in a lifetime. The presentation underscores the necessity for dermatologists to provide evidence-based education, set realistic expectations, and advocate for cost-effective strategies to alleviate the financial burden associated with hair loss management.

View more

Conclusions

  • The alopecia market is projected to grow significantly, indicating a robust demand for hair loss treatments.
  • Women spend considerably more on hair products compared to men, reflecting differing levels of investment in personal grooming.
  • Natural hair care and sustainability are emerging trends in the hair care market.
  • Black women disproportionately spend significantly more on ethnic hair products compared to non-Black women, highlighting a market disparity.
  • Patients with hair loss show a strong willingness to pay for effective treatments, with many ready to invest substantial amounts for a permanent solution.
  • Alopecia areata poses a significant economic burden due to higher healthcare costs and the need for psychological support among affected individuals.
  • Low-dose oral minoxidil has emerged as a promising treatment option for androgenetic alopecia, with potential cost benefits over traditional treatments.
  • Management of hair loss is a long-term commitment, and patients should be educated on realistic expectations regarding treatment outcomes.
  • Compounded medications can carry risks of dosing errors, warranting caution in their prescription and use.
  • Overall, there is a need for informed discussions about treatment effectiveness, costs, and psychological impacts related to hair loss.
  • Miteva M. (2023) Minority hair tax: pricing bias in haircare products. International Journal of Women's Dermatology 9(2):p e089, June 2023. DOI: 10.1097/JW9.0000000000000089
  • Okhovat J-P, Grogan T, Duan L, Goh C. (2021) Willingness to Pay and QOL in Alopecia Areata. Journal of the European Academy of Dermatology and Venereology. 35(2):288-297. DOI: 10.1111/jdv.16985
  • Ray M, Swallow E, Gandhi K, et al. (2022) Healthcare utilization and costs among US adolescents with alopecia areata. Journal of Health Economics and Outcomes Research 9(2):11-18.
  • Beikert F et al. (2014) Willingness to pay in AGA patients for a permanent cure. Journal of the European Academy of Dermatology and Venereology. 35(5):531-536. DOI: 10.1111/jdv.12224
  • Kanti V, et al. (2018) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. Journal of the European Academy of Dermatology and Venereology, 32:11-22.
  • Dmitriev A. (2021) Low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. Journal of the American Academy of Dermatology 84(6):1644-1651. DOI: 10.1016/j.jaad.2021.02.081.